Document is current
Any future updates will be listed below
-
Authors
Lei, Ruixue
Zhao, Yanteng
Huang, Kai
Wang, Qian
Wan, Kangkang
Li, Tingting
Yang, Haijun
Lv, Xianping
- License Information
-
More Information
Article History
Received: 27 October 2021
Accepted: 17 February 2022
First Online: 28 February 2022
Declarations
:
: Wuhan Ammunition Life-tech Company, Ltd. has applied for the patent relating to the dual targets of <i>SDC2</i> and <i>TFPI2</i>. The other authors declare no conflict of interest.
: Approval for this study was obtained from the Ethics Committee of Zhongnan Hospital of Wuhan University (No. 2019099). All experiments were performed in accordance with relevant guidelines and regulations. Written informed consent was obtained from individual or guardian participants.
: Not applicable.
: Wuhan Ammunition Life-tech Company, Ltd. has applied for the patent relating to the dual targets of <i>SDC2</i> and <i>TFPI2</i>. The other authors declare no conflict of interest.
